0001140361-15-025097.txt : 20150622 0001140361-15-025097.hdr.sgml : 20150622 20150622215721 ACCESSION NUMBER: 0001140361-15-025097 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150618 FILED AS OF DATE: 20150622 DATE AS OF CHANGE: 20150622 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Raptor Pharmaceutical Corp CENTRAL INDEX KEY: 0001070698 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 860883978 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7 HAMILTON LANDING STREET 2: SUITE 100 CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-408-6200 MAIL ADDRESS: STREET 1: 7 HAMILTON LANDING STREET 2: SUITE 100 CITY: NOVATO STATE: CA ZIP: 94949 FORMER COMPANY: FORMER CONFORMED NAME: Raptor Pharmaceutical Corp. DATE OF NAME CHANGE: 20090929 FORMER COMPANY: FORMER CONFORMED NAME: TorreyPines Therapeutics, Inc. DATE OF NAME CHANGE: 20061003 FORMER COMPANY: FORMER CONFORMED NAME: AXONYX INC DATE OF NAME CHANGE: 19990303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Daley Thomas E CENTRAL INDEX KEY: 0001420859 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25571 FILM NUMBER: 15946000 MAIL ADDRESS: STREET 1: C/O RAPTOR PHARMACEUTICALS CORP. STREET 2: 9 COMMERCIAL BLVD., SUITE 200 CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2015-06-18 0 0001070698 Raptor Pharmaceutical Corp RPTP 0001420859 Daley Thomas E C/O RAPTOR PHARMACEUTICAL CORP. 7 HAMILTON LANDING, SUITE 100 NOVATO CA 94949 0 1 0 0 Chief Business Officer Common Stock 2015-06-18 4 S 0 30000 15.00 D 34719 D Common Stock 2015-06-18 4 M 0 5000 3.54 A 39719 D Common Stock 2015-06-18 4 S 0 5000 15.00 D 34719 D Common Stock 3.54 2015-06-18 4 M 0 5000 0 A 2020-11-22 Stock options (right to buy) 5000 62864 D Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 26, 2014. Includes 11,500 Restricted Stock Units ("RSUs") granted on February 9, 2015. The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof. Fully vested and exercisable. /s/ Mark Jones, Raptor Pharmaceutical Corp., Attorney-in-Fact 2015-06-22